Clinical trials
Phase 1/2 Purpura, Thrombocytopenic, Idiopathic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2014 | 1 |
| 2015 | 3 |
| 2018 | 2 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 8 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 9 |
| Completed | 7 |
| Terminated | 4 |
| Not yet recruiting | 3 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking University People's Hospital | 3 |
| Amgen | 2 |
| Protalex, Inc. | 2 |
| 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | 1 |
| Alpine Immune Sciences Inc, A Subsidiary of Vertex | 1 |
| Bristol-Myers Squibb | 1 |
| CRISPR Therapeutics AG | 1 |
| Children's Hospital of Philadelphia | 1 |
| Climb Bio, Inc. | 1 |
| Cullinan Therapeutics Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Purpura, Thrombocytopenic, Idiopathic | 25 |
| Thrombocytopenia | 4 |
| Anemia, Hemolytic | 3 |
| Anemia, Hemolytic, Autoimmune | 3 |
| Purpura, Thrombocytopenic | 2 |
| Anemia | 1 |
| Arthritis, Rheumatoid | 1 |
| Autoimmune Diseases | 1 |
| Autoimmune Lymphoproliferative Syndrome | 1 |
| Blood Platelet Disorders | 1 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.